Welcome to our dedicated page for SCNNF news (Ticker: SCNNF), a resource for investors and traders seeking the latest updates and insights on SCNNF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SCNNF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SCNNF's position in the market.
Sativa Wellness Group announced significant changes to its board on February 4, 2021. Geremy Thomas and George Thomas have been appointed as directors, with Geremy also assuming the role of Executive Chairman and interim CEO. Henry Lees-Buckley is no longer CEO, while Joseph Colliver will continue as CFO during a transitional period. Jonathan Wearing and Angus Kerr resigned from the Board. Clive Thomas Standish has been added as a Non-Executive Director, bringing extensive industry experience. The company aims to focus on cash-generating activities and cost reductions.
Sativa Wellness Group has announced a change in its fiscal year end from July 31 to December 31, effective immediately. This adjustment aims to align its reporting cycle with its operating subsidiaries, reducing administrative expenses related to multiple reporting periods. The company expects to report interim financial statements for the three months ending October 31, 2020 by the end of December 2020, and audited financials for the year ending December 31, 2020 by the end of April 2021.
Sativa Wellness Group has launched a private COVID-19 testing clinic in its Goodbody Wellness store in Bath, effective November 19, 2020. The clinic offers PCR, antigen, and antibody testing, with PCR tests priced at £155, yielding results within 48-72 hours, while rapid antigen tests are available for £75 with results in 15 minutes. Strong pre-booking demand indicates community interest. This initiative aligns with ongoing government travel requirements and aims to support health and wellness during the pandemic.
Stillcanna Inc. announced that its partner, Sativa Group PLC, has joined the Association for the Cannabinoid Industry (ACI) to participate in a toxicology study aimed at compliance with Novel Food regulations. This initiative is crucial for ensuring the safety of CBD products post-March 31, 2021. Sativa's team is working closely with ACI to meet rigorous quality standards, with raw materials and final products undergoing third-party testing. The company intends to submit its Novel Food application, further enhancing its commitment to high-quality, compliant products.
Stillcanna Inc. (CSE:STIL) has received conditional approval from the Canadian Securities Exchange for the listing of its shares following a merger with Sativa Group PLC, which has been sanctioned by the UK High Court. The company will rebrand as Sativa Wellness Group Inc. with the new ticker SWEL and plans to list on various markets including AQSE and OTC. A new executive team has been appointed, aiming to enhance operational efficiency in CBD production, bolstered by a recent acquisition.
VANCOUVER, BC / ACCESSWIRE / Stillcanna Inc. (OTC PINK:SCNNF) announces that shareholders voted 97.5% in favor of acquiring the UK's Sativa Group PLC during a meeting on August 27, 2020. With 37,222,254 shares represented, the acquisition awaits final regulatory approvals for trading resumption under "The Sativa Group" in Canada, the USA, and Frankfurt. The merger aims to consolidate supply chain control from seed to consumer, optimizing quality and cost in cannabis production.
Stillcanna Inc. (OTC PINK:SCNNF) announced that shareholders of Sativa Group PLC have overwhelmingly approved its acquisition, with a special shareholder meeting scheduled for August 27, 2020. Stillcanna plans to resume trading in September, following the completion of the acquisition and listing on the AQSE. Stillcanna has secured all necessary licenses for CBD manufacturing at its ORIGIN extraction facility. However, it terminated its joint venture agreement with Dragonfly Biosciences due to alleged breaches, and is pursuing legal action against them for damages and ownership claims.
